{"entity":{"type":"insider","cik":"0001262326","url":"/insider/0001262326","json_url":"/insider/0001262326.json","name":"Mirabelli Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":18,"first":"2004-06-02","last":"2026-03-30","span_basis":"filed_date"},"name_variants":[{"name":"Mirabelli Christopher","source":"filing","n_filings":15,"first_seen":"2007-04-13","last_seen":"2026-03-30"},{"name":"MIRAELLI CHRISTOPHER","source":"filing","n_filings":3,"first_seen":"2004-06-02","last_seen":"2005-06-21"}],"transactions":[{"id":5795871,"accession":"0001104659-26-036804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-036804","line_url":"/filing/0001104659-26-036804#line-1","is_derivative":false,"issuer_cik":"0001262326","issuer_name":"CYPHERPUNK TECHNOLOGIES INC.","issuer_ticker":"CYPH","issuer_name_source":null,"issuer_url":"/issuer/0001262326","owner_cik":"0001262326","owner_name":"Mirabelli Christopher","owner_display_name":"Mirabelli Christopher","owner_url":"/insider/0001262326","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":0.7105,"price_display":"0.71","price_state":"stated","total_value":42630.0,"total_display":"42,630.00","total_whole":"42,630","shares_owned_after":130376.0,"shares_owned_after_display":"130,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-30","scope":"insider"},{"id":4168569,"accession":"0001104659-25-114094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-114094","line_url":"/filing/0001104659-25-114094","is_derivative":false,"issuer_cik":"0001262326","issuer_name":"CYPHERPUNK TECHNOLOGIES INC.","issuer_ticker":"CYPH","issuer_name_source":null,"issuer_url":"/issuer/0001262326","owner_cik":"0001262326","owner_name":"Mirabelli Christopher","owner_display_name":"Mirabelli Christopher","owner_url":"/insider/0001262326","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":676319.0,"shares_display":"676,319","price_per_share":3.14,"price_display":"3.14","price_state":"stated","total_value":2123641.66,"total_display":"2,123,641.66","total_whole":"2,123,642","shares_owned_after":2136.0,"shares_owned_after_display":"2,136","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider","n_lines":2},{"id":8475722,"accession":"0001104659-19-005836","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-005836","line_url":"/filing/0001104659-19-005836#line-1","is_derivative":false,"issuer_cik":"0001262326","issuer_name":"LEAP THERAPEUTICS, INC.","issuer_ticker":"LPTX","issuer_name_source":null,"issuer_url":"/issuer/0001262326","owner_cik":"0001262326","owner_name":"Mirabelli Christopher","owner_display_name":"Mirabelli Christopher","owner_url":"/insider/0001262326","role":"Director, Officer (CEO, President, Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President, Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":571428.0,"shares_display":"571,428","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":999999.0,"total_display":"999,999.00","total_whole":"999,999","shares_owned_after":4114804.0,"shares_owned_after_display":"4,114,804","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-05","scope":"insider"},{"id":4696962,"accession":"0001104659-17-069117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-069117","line_url":"/filing/0001104659-17-069117#line-1","is_derivative":false,"issuer_cik":"0001262326","issuer_name":"LEAP THERAPEUTICS, INC.","issuer_ticker":"LPTX","issuer_name_source":null,"issuer_url":"/issuer/0001262326","owner_cik":"0001262326","owner_name":"Mirabelli Christopher","owner_display_name":"Mirabelli Christopher","owner_url":"/insider/0001262326","role":"Director, Officer (CEO, President, COB), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1057769.0,"shares_display":"1,057,769","price_per_share":6.085,"price_display":"6.08","price_state":"stated","total_value":6436524.365,"total_display":"6,436,524.36","total_whole":"6,436,524","shares_owned_after":3573376.0,"shares_owned_after_display":"3,573,376","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-14","filed_date":"2017-11-16","scope":"insider"},{"id":2127309,"accession":"0001209191-16-100441","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-100441","line_url":"/filing/0001209191-16-100441#line-3","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"GLOBEIMMUNE INC","issuer_ticker":"GBIM","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LAWLOR AUGUSTINE; WERNER HAROLD R; CAVANAUGH JAMES H; HealthCare Partners VII, L.P.; LITTLECHILD JOHN W; Mirabelli Christopher; HEALTHCARE VENTURES VII LP","owner_display_name":"LAWLOR AUGUSTINE","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":6950.0,"total_display":"6,950.00","total_whole":"6,950","shares_owned_after":554267.0,"shares_owned_after_display":"554,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-19","filed_date":"2016-02-19","scope":"insider"},{"id":2127305,"accession":"0001209191-16-100441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-100441","line_url":"/filing/0001209191-16-100441#line-2","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"GLOBEIMMUNE INC","issuer_ticker":"GBIM","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LAWLOR AUGUSTINE; WERNER HAROLD R; CAVANAUGH JAMES H; HealthCare Partners VII, L.P.; LITTLECHILD JOHN W; Mirabelli Christopher; HEALTHCARE VENTURES VII LP","owner_display_name":"LAWLOR AUGUSTINE","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":7000.0,"total_display":"7,000.00","total_whole":"7,000","shares_owned_after":559267.0,"shares_owned_after_display":"559,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-18","filed_date":"2016-02-19","scope":"insider"},{"id":2127299,"accession":"0001209191-16-100441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-100441","line_url":"/filing/0001209191-16-100441#line-1","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"GLOBEIMMUNE INC","issuer_ticker":"GBIM","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LAWLOR AUGUSTINE; WERNER HAROLD R; CAVANAUGH JAMES H; HealthCare Partners VII, L.P.; LITTLECHILD JOHN W; Mirabelli Christopher; HEALTHCARE VENTURES VII LP","owner_display_name":"LAWLOR AUGUSTINE","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":7650.0,"total_display":"7,650.00","total_whole":"7,650","shares_owned_after":564267.0,"shares_owned_after_display":"564,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-19","scope":"insider"},{"id":2068407,"accession":"0000899243-16-013608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-013608","line_url":"/filing/0000899243-16-013608#line-2","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"WERNER HAROLD R; HealthCare Partners VIII, L.P.; LITTLECHILD JOHN W; Mirabelli Christopher; HealthCare Ventures VIII, L.P.; HealthCare Partners VIII, LLC; CAVANAUGH JAMES H; LAWLOR AUGUSTINE","owner_display_name":"WERNER HAROLD R","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375000.0,"shares_display":"375,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":2149295.0,"shares_owned_after_display":"2,149,295","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-17","scope":"insider"},{"id":2309903,"accession":"0001209191-16-098769","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-098769","line_url":"/filing/0001209191-16-098769#line-3","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"GLOBEIMMUNE INC","issuer_ticker":"GBIM","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LAWLOR AUGUSTINE; Mirabelli Christopher; WERNER HAROLD R; LITTLECHILD JOHN W; HealthCare Partners VII, L.P.; HEALTHCARE VENTURES VII LP; CAVANAUGH JAMES H","owner_display_name":"LAWLOR AUGUSTINE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.51,"price_display":"1.51","price_state":"stated","total_value":7550.0,"total_display":"7,550.00","total_whole":"7,550","shares_owned_after":569267.0,"shares_owned_after_display":"569,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-16","filed_date":"2016-02-16","scope":"insider"},{"id":2309897,"accession":"0001209191-16-098769","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-098769","line_url":"/filing/0001209191-16-098769#line-2","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"GLOBEIMMUNE INC","issuer_ticker":"GBIM","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LAWLOR AUGUSTINE; Mirabelli Christopher; WERNER HAROLD R; LITTLECHILD JOHN W; HealthCare Partners VII, L.P.; HEALTHCARE VENTURES VII LP; CAVANAUGH JAMES H","owner_display_name":"LAWLOR AUGUSTINE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.59,"price_display":"1.59","price_state":"stated","total_value":7950.0,"total_display":"7,950.00","total_whole":"7,950","shares_owned_after":574267.0,"shares_owned_after_display":"574,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-12","filed_date":"2016-02-16","scope":"insider"},{"id":2309887,"accession":"0001209191-16-098769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-098769","line_url":"/filing/0001209191-16-098769#line-1","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"GLOBEIMMUNE INC","issuer_ticker":"GBIM","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LAWLOR AUGUSTINE; Mirabelli Christopher; WERNER HAROLD R; LITTLECHILD JOHN W; HealthCare Partners VII, L.P.; HEALTHCARE VENTURES VII LP; CAVANAUGH JAMES H","owner_display_name":"LAWLOR AUGUSTINE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":8600.0,"total_display":"8,600.00","total_whole":"8,600","shares_owned_after":579267.0,"shares_owned_after_display":"579,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-11","filed_date":"2016-02-16","scope":"insider"},{"id":7015123,"accession":"0001209191-14-046450","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-046450","line_url":"/filing/0001209191-14-046450#line-5","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"GLOBEIMMUNE INC","issuer_ticker":"GBIM","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LITTLECHILD JOHN W; WERNER HAROLD R; HealthCare Partners VII, L.P.; LAWLOR AUGUSTINE; CAVANAUGH JAMES H; HEALTHCARE VENTURES VII LP; Mirabelli Christopher","owner_display_name":"LITTLECHILD JOHN W","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":190000.0,"shares_display":"190,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1900000.0,"total_display":"1,900,000.00","total_whole":"1,900,000","shares_owned_after":584267.0,"shares_owned_after_display":"584,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-08","filed_date":"2014-07-08","scope":"insider"},{"id":6967085,"accession":"0001209191-14-008252","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-008252","line_url":"/filing/0001209191-14-008252#line-4","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"CAVANAUGH JAMES H; HealthCare Ventures VIII, L.P.; LITTLECHILD JOHN W; Mirabelli Christopher; WERNER HAROLD R; LAWLOR AUGUSTINE; HealthCare Partners VIII, L.P.; HealthCare Partners VIII, LLC","owner_display_name":"CAVANAUGH JAMES H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":297058.0,"shares_display":"297,058","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2079406.0,"total_display":"2,079,406.00","total_whole":"2,079,406","shares_owned_after":2446251.0,"shares_owned_after_display":"2,446,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-07","scope":"insider"},{"id":4652527,"accession":"0001209191-13-057535","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-13-057535","line_url":"/filing/0001209191-13-057535#line-6","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"ONSI DOUGLAS E; HEALTHCARE VENTURES VII LP; HealthCare Partners VII, L.P.; Mirabelli Christopher; LAWLOR AUGUSTINE; CAVANAUGH JAMES H; WERNER HAROLD R; LITTLECHILD JOHN W","owner_display_name":"ONSI DOUGLAS E","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":713463.0,"shares_display":"713,463","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":4994241.0,"total_display":"4,994,241.00","total_whole":"4,994,241","shares_owned_after":2586466.0,"shares_owned_after_display":"2,586,466","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-17","filed_date":"2013-12-17","scope":"insider"},{"id":5646831,"accession":"0001209191-09-048013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-048013","line_url":"/filing/0001209191-09-048013#line-1","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LITTLECHILD JOHN W; HealthCare Ventures VIII, L.P.; CAVANAUGH JAMES H; WERNER HAROLD R; HealthCare Partners VIII, L.P.; HealthCare Partners VIII, LLC; LAWLOR AUGUSTINE; Mirabelli Christopher","owner_display_name":"LITTLECHILD JOHN W","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1570680.0,"shares_display":"1,570,680","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":3041268.0,"shares_owned_after_display":"3,041,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-10-05","filed_date":"2009-10-07","scope":"insider"},{"id":9276036,"accession":"0001231919-07-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-07-000111","line_url":"/filing/0001231919-07-000111#line-1","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"PHARMATHENE, INC","issuer_ticker":"HAQ","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"CAVANAUGH JAMES H; HEALTHCARE VENTURES VII LP; HealthCare Partners VII, L.P.; LAWLOR AUGUSTINE; LITTLECHILD JOHN W; Mirabelli Christopher; WERNER HAROLD R","owner_display_name":"CAVANAUGH JAMES H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock, $.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":7.66,"price_display":"7.66","price_state":"stated","total_value":957500.0,"total_display":"957,500.00","total_whole":"957,500","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-03","filed_date":"2007-11-13","scope":"insider"},{"id":7481478,"accession":"0001231919-07-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-07-000065","line_url":"/filing/0001231919-07-000065#line-2","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"HEALTHCARE ACQUISITION CORP","issuer_ticker":"HAQ","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"CAVANAUGH JAMES H; AGUIAR ERIC; LAWLOR AUGUSTINE; Mirabelli Christopher; HEALTHCARE VENTURES VII LP; LITTLECHILD JOHN W; HealthCare Partners VII, L.P.; WERNER HAROLD R","owner_display_name":"CAVANAUGH JAMES H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":7.66,"price_display":"7.66","price_state":"stated","total_value":957500.0,"total_display":"957,500.00","total_whole":"957,500","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-03","filed_date":"2007-08-07","scope":"insider"},{"id":7088415,"accession":"0001231919-07-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-07-000064","line_url":"/filing/0001231919-07-000064#line-2","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"ACTIVBIOTICS INC","issuer_ticker":"HAQ","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LITTLECHILD JOHN W; HEALTHCARE VENTURES VII LP; CAVANAUGH JAMES H; WERNER HAROLD R; AGUIAR ERIC; HealthCare Partners VII, L.P.; LAWLOR AUGUSTINE; Mirabelli Christopher","owner_display_name":"LITTLECHILD JOHN W","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":7.66,"price_display":"7.66","price_state":"stated","total_value":957500.0,"total_display":"957,500.00","total_whole":"957,500","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-03","filed_date":"2007-08-07","scope":"insider"},{"id":6990183,"accession":"0001231919-07-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-07-000029","line_url":"/filing/0001231919-07-000029#line-1","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"ADVANCIS PHARMACEUTICAL CORP","issuer_ticker":"AVNC","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"CAVANAUGH JAMES H; HEALTHCARE VENTURES VI LP; CROUSE WILLIAM W; AGUIAR ERIC; LAWLOR AUGUSTINE; HEALTHCARE PARTNERS VI LP; LITTLECHILD JOHN W; WERNER HAROLD R; Mirabelli Christopher","owner_display_name":"CAVANAUGH JAMES H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":682903.0,"shares_display":"682,903","price_per_share":2.3637,"price_display":"2.36","price_state":"stated","total_value":1614177.8211,"total_display":"1,614,177.82","total_whole":"1,614,178","shares_owned_after":6215389.0,"shares_owned_after_display":"6,215,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-12","filed_date":"2007-04-13","scope":"insider"},{"id":1405232,"accession":"0001231919-05-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-05-000050","line_url":"/filing/0001231919-05-000050#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001262326","owner_name":"MIRAELLI CHRISTOPHER","owner_display_name":"MIRAELLI CHRISTOPHER","owner_url":"/insider/0001262326","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1094891.0,"shares_display":"1,094,891","price_per_share":5.48,"price_display":"5.48","price_state":"stated","total_value":6000002.68,"total_display":"6,000,002.68","total_whole":"6,000,003","shares_owned_after":5153323.0,"shares_owned_after_display":"5,153,323","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-06-20","filed_date":"2005-06-21","scope":"insider"},{"id":9276017,"accession":"0001231919-04-000200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-04-000200","line_url":"/filing/0001231919-04-000200#line-1","is_derivative":false,"issuer_cik":"0001013473","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001013473","owner_cik":null,"owner_name":"AGUIAR ERIC; CAVANAUGH JAMES H; CROUSE WILLIAM; HEALTHCARE PARTNERS VI LP; HEALTHCARE VENTURES VI LP; LAWLOR AUGUSTINE; LITTLECHILD JOHN W; MIRAELLI CHRISTOPHER; WERNER HAROLD R","owner_display_name":"AGUIAR ERIC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357100.0,"shares_display":"357,100","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2499700.0,"total_display":"2,499,700.00","total_whole":"2,499,700","shares_owned_after":4058432.0,"shares_owned_after_display":"4,058,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2004-07-09","scope":"insider"},{"id":227981,"accession":"0001231919-04-000175","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-04-000175","line_url":"/filing/0001231919-04-000175#line-3","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LAWLOR AUGUSTINE; CAVANAUGH JAMES H; HEALTHCARE PARTNERS VI LP; CROUSE WILLIAM; AGUIAR ERIC; WERNER HAROLD R; HEALTHCARE VENTURES VI LP; LITTLECHILD JOHN W; MIRAELLI CHRISTOPHER","owner_display_name":"LAWLOR AUGUSTINE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357100.0,"shares_display":"357,100","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2499700.0,"total_display":"2,499,700.00","total_whole":"2,499,700","shares_owned_after":4058432.0,"shares_owned_after_display":"4,058,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2004-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001509745","name":"CYPHERPUNK TECHNOLOGIES INC.","url":"/issuer/0001509745","role":"Director, Officer (CEO, President, Chairman), Ten percent owner","n_filings":4,"first_seen":"2017-11-16","last_seen":"2026-03-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001245104","name":"GLOBEIMMUNE INC","url":"/issuer/0001245104","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2014-07-08","last_seen":"2016-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001445283","name":"PROTEOSTASIS THERAPEUTICS, INC.","url":"/issuer/0001445283","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2016-02-17","last_seen":"2016-02-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001429560","name":"TREVENA INC","url":"/issuer/0001429560","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2014-02-07","last_seen":"2014-02-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001361248","name":"TETRALOGIC PHARMACEUTICALS CORP","url":"/issuer/0001361248","role":"Ten percent owner","n_filings":1,"first_seen":"2013-12-17","last_seen":"2013-12-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001183765","name":"THRESHOLD PHARMACEUTICALS INC","url":"/issuer/0001183765","role":"Ten percent owner","n_filings":1,"first_seen":"2009-10-07","last_seen":"2009-10-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001326190","name":"PHARMATHENE, INC","url":"/issuer/0001326190","role":"Ten percent owner","n_filings":2,"first_seen":"2007-08-07","last_seen":"2007-11-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001234620","name":"ACTIVBIOTICS INC","url":"/issuer/0001234620","role":"Ten percent owner","n_filings":1,"first_seen":"2007-08-07","last_seen":"2007-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001161924","name":"ADVANCIS PHARMACEUTICAL CORP","url":"/issuer/0001161924","role":"Ten percent owner","n_filings":1,"first_seen":"2007-04-13","last_seen":"2007-04-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001145404","name":"CRITICAL THERAPEUTICS INC","url":"/issuer/0001145404","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2004-06-02","last_seen":"2005-06-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001262326","retrieved_at":"2026-08-25T09:32:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}